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Is there  a role for  regenerative  medicine  in  chronic
rhinosinusitis with  nasal  polyps?
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During  the  past  ﬁve  years,  over  than  1600  articles  have  been
published  on  the  subject  of  Chronic  Rhinosinusitis  with  Nasal
Polyps  (CRSwNP).  Despite  this,  its  physiopathology  remains
incompletely  understood.  CRSwNP  is  an  overt  and  reverber-
ant  inﬂammatory  disease,  which  leads  to  the  recruitment
of  several  inﬂammatory  cells,  characterized  by  the  pres-
ence  of  eosinophils,  neutrophils,  and  mast  cells.1 Although  a
Th2-driven  response  was  initially  thought  to  be  the  principal
inﬂammatory  mechanisms  present  in  CRSwNP,  it  is  now  rec-
ognized  that  both  Th1  and  Th2  responses  can  be  observed
in  patients  with  CRSwNP,  depending  on  ethnicity  or  on  asso-
ciated  diseases.1 As  example,  Asian  patients  and  those  with
cystic  ﬁbrosis  tend  to  present  more  of  a  Th1-skewed  inﬂam-
matory  proﬁle  as  compared  to  European  nasal  polyps.  It
should  be  noted  that  the  reason  for  such  an  intense  inﬂam-
matory  process,  and  the  different  inﬂammatory  patterns  is
still  poorly  understood.
An  increased  appreciation  of  the  potential  role  of  the
nasal  epithelium  and  its  associated  barrier  and  defensive
functions  may  help  improve  our  insights  into  CRS  patho-
genesis.  Emerging  evidence1--3 increasingly  documents  that
nasal  epithelial  cells  are  not  simply  passive  barriers  between
host  interior  and  exterior  environments,  but  instead  play  an
active  role  in  modulating  and  coordinating  host  responses  to
the  external  environment.  They  are  capable  of  monitoring
the  environment  for  threats  via  pathogen  detection,  and  can
mount  defensive  responses  by  inducing  signaling  pathways,
with  generation  of  subsequent  inﬂammation  and  cellular
recruitment.
The  integrity  of  the  epithelial  barrier  is  determined  by
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amily),  adherens  junctions  (composed  by  E-cadherin  and
atenins)  and  desmosomes  (composed  mostly  by  desmoglein
nd  desmocollin).2 All  these  molecules  regulate  cell-to-cell
ermeability,  and  are  associated  with  different  pathways,
ith  distinct  roles  in  homeostasis.
An  impaired  epithelial  barrier  could  be  a rational  cause
or  a reverberant  process  since  increased  permeability  to
llergens,  pollutants,  bacteria,  viruses,  fungi,  and  others4
ould  facilitate  their  penetration  through  into  the  superﬁ-
ial  layer.  In  addition,  this  could  contribute  to  dysregulated
on  and  ﬂuid  transport  through  epithelial  cells  as  well
s  altered  cellular  function.  In  support  of  this,  disrupted
pithelia  have  now  been  proven  to  promote  a  Th2  signaling
t  lower  airways,4 and  asthma,  chronic  rhinosinusitis  and,
ore  recently  allergic  rhinitis2 have  recently  been  asso-
iated  with  lower  expression  of  tight  junction  proteins.
ntriguingly,  these  disorders  are  also  share  similar  genetic
nderpinnings.5
However,  little  is  known  about  the  potential  causes  for
his  barrier  defects  and  its  real  impact  on  CRSwNP.  Do
pithelial  defects  lead  to  inﬂammation,  or  is  the  contrary,
ith  environmental  agents  contributing  to  dysfunctional
pithelium?
Our  group6,7 has  previously  performed  pooled  Genome-
ide  Association  Study  (GWAS)  to  evaluate  possible  genetic
olymorphisms  associated  with  CRS.  Among  the  potential
00  genes  identiﬁed,  the  most  importantly  related  ones
ere  LAMA2  (laminin-2)  and  LAMB1  (laminin-1).  Laminins
re  essential  proteins  at  basal  lamina,  thus  this  result  sug-
ests  that  genetic  disturbance(s)  in  cellular  components  may
ead  to  epithelial  dysfunction  in  CRS.
Conversely,  other  studies  have  demonstrated  that  the
pithelial  barrier  could  be  compromised  by  extrinsic  fac-
ors.  In  particular,  the  observed  inﬂammation  in  CRS  may
ontribute  to  epithelial  dysfunction.  Wise  et  al.3 showed
hat  primary  nasal  epithelial  cells,  when  exposed  to  IL-4
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nd  IL-13,  presented  lower  expression  of  JAM-A  (junctional
dhesion  molecule  A)  and  E-cadherin,  with  consequent
iminished  transepithelial  resistance.  A  similar  pattern  was
bserved  by  Ramezanpour  et  al.8 after  primary  nasal  epithe-
ial  cells  were  exposed  to  Th17  cytokines  (IL-17,  IL-22,  and
L-26).
Bacterial  factors  may  also  play  a  role.  Our  group
as  demonstrated  that  primary  nasal  epithelial  cells,
hen  exposed  to  Pseudomonas  aeruginosa  diffuse  mate-
ial  (PsaDM),  exhibited  a  lower  capability  to  repair  wounds
ollowing  injury,  and  also  manifest  a  signiﬁcant  reduc-
ion  in  cystic  ﬁbrosis  transmembrane  conductance  regulator
CFTR)  expression  and  function,  even  in  non-cystic  ﬁbrosis
atients.9,10 This  ﬁnding  is  especially  important  after  the
escription,  also  by  our  group,11 that  inhibiting  CFTR  in  non-
F  nasal  polyps  signiﬁcantly  inhibited  wound  closure.
These  inﬂammatory  and  infectious  components  may  not
nly  affect  mature,  differentiated  cells  but  may  also  impact
pithelial  progenitor  cells,  thus  interfering  with  epithe-
ial  regeneration  and  reparative  processes  in  response  to
njury.  Yu  et  al.12 demonstrated  that  epithelial  basal  cells
rom  nasal  polyps  grow  and  proliferate  slower  than  control
ucosa,  when  both  are  submitted  to  the  same  experimen-
al  conditions.  Moreover,  in  our  own  work,  we  observed
hat  undifferentiated  basal  cell  cultures  raised  from  patients
ith  CRSwNP  (without  CF)  exhibited  lower  wound  healing
ates  than  controls  (unpublished  data).
All  those  ﬁndings  suggest  that  epithelial  repair  is
mpaired  in  patients  with  CRSwNP  and  that  regenerative
edicine  in  this  disease  has  been  poorly  explored  until
ow.  Enhanced  epithelial  repair  could  interfere  with  the
everberant  inﬂammatory  pattern  present  in  patients  with
hronic  rhinosinusitis,  thus  allowing  disease  resolution.  This
uggests  it  may  represent  an  interesting  novel  therapeutic
arget,  which  could  be  addressed  irrespectively  of  whether
he  cause  was  genetic  or  induced  by  external  agents.
hile  most  researches  on  regenerative  medicine  today  have
ocused  on  the  use  of  stem  cells,13,14 other  therapeutic
pproaches  aimed  at  improving  epithelial  regeneration  and
epair  may  offer  a  beneﬁt  in  treating  CRSwNP,  either  as
n  isolated  therapy,  or  concomitantly  with  current  anti-
acterial  and  immunomodulatory  strategies.
Continued  efforts  to  better  understand  the  mechanisms
f  wound  healing  and  epithelial  repair/regeneration  in
RSwNP  may  thus  yield  novel  therapeutic  approaches  for
RSwNP.  By  targeting  this  novel  element  of  CRS  pathogene-
is  which  has  until  now  not  been  addressed,  we  may  usher
n  a  new  era  in  CRS  treatment,  thus  improving  outcomes  for
ur  CRS  patients.
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